United States – 24 October 2025 – The U.S. Food and Drug Administration (FDA) has announced a major change to the way medical device manufacturers manage quality systems. In January 2024, the agency issued a final rule revising 21 CFR Part 820, known as the Quality System Regulation (QSR). This update brings the U.S. framework in line with ISO 13485:2016, the international standard for medical device quality management systems. The updated regulation will now be called the Quality Management System Regulation (QMSR) and will take effect on February 2, 2026.
Why the FDA QMSR Change Matters
For years, manufacturers selling in both U.S. and international markets have maintained two separate quality systems, one for FDA compliance and another for ISO certification. The new QMSR eliminates much of that duplication by aligning both systems. According to the FDA, ISO 13485 already provides a similar level of quality assurance and control, so integrating it into U.S. regulations makes compliance more consistent worldwide.
Key Highlights of the New Rule
- Effective Date: The new rule takes effect on February 2, 2026. Until that date, companies must continue following the current QSR requirements.
- Broader Inspection Authority: FDA inspectors will now be able to review internal audits, supplier evaluations, and management reviews records that were previously exempt.
- End of QSIT: The long-used Quality System Inspection Technique (QSIT) will be replaced by a new inspection model based on QMSR principles.
- Comparative Preparation: Manufacturers are encouraged to carry out a gap assessment between their existing QSR procedures and ISO 13485 to identify areas that need updating.
Impact of ISO 13485 Compliance on Manufacturers
This transition will bring both challenges and advantages. For companies already certified to ISO 13485, compliance efforts will be simpler, as one system will now satisfy both FDA and international expectations. However, manufacturers must ensure that their documentation, procedures, and records meet both ISO requirements and specific FDA expectations under the QMSR. The FDA will begin enforcing the new system in early 2026, and inspections after that date will follow the updated model.
How Morulaa Healthtech Supports Manufacturers
At Morulaa Healthtech, we support medical device manufacturers in understanding and adapting to regulatory changes like the QMSR. Our consulting team assists with:
- Gap analysis between QSR and ISO 13485 systems
- Quality documentation updates and risk management alignment
- Inspection readiness for the new QMSR framework
By preparing early, companies can ensure a smooth transition and maintain uninterrupted market access once the new rule becomes effective.